Ignite Creation Date:
2024-05-06 @ 12:04 AM
Last Modification Date:
2024-10-26 @ 10:44 AM
Study NCT ID:
NCT01484119
Status:
COMPLETED
Last Update Posted:
2018-09-28
First Post:
2011-11-29
Brief Title:
Efficacy Safety and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Sponsor:
Idorsia Pharmaceuticals Ltd
Organization:
Idorsia Pharmaceuticals Ltd
Study Overview
Official Title:
Multi-center Double-blind Double-dummy Randomized Placebo-controlled Active-reference Parallel-group Study to Evaluate the Efficacy Safety and Tolerability of ACT-129968 in Adolescent Adult Elderly Patients With Seasonal Allergic Rhinitis
Status:
COMPLETED
Status Verified Date:
2018-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SAR
Brief Summary:
This study will assess the efficacy and safety of ACT-129968 in adolescent adult and elderly patients with seasonal allergic rhinitis due to mountain cedar pollen
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None